Yang Y, Dieter MZ, Chen Y, Shertzer HG, Nebert DW, Dalton TP: Initial characterization of the glutamate-cysteine ligase modifier subunit Gclm(-/-) knockout mouse
Maintenance requires a different plan Often, the decision to quit is driven by financial considerations, including the high costs of GLP1s and decisions by many insurers not to cover them for weight loss alone, says James O
Bone health is the one women should not overlook
In a research conducted at the University of Chicago, it was found that the health benefits that these drugs may offer in the long run could compensate for the high initial costs, though they must be made available to a wider population
Whilst back pain is not listed as a common side effect in the Summary of Product Characteristics for these medications, some patients report musculoskeletal discomfort during treatment